On the Beat: A Safety Mechanism for Heart Cell Therapies - Melissa Suma

Year
2025
Organisation
Summary

This research develops a gene-engineered safety switch for stem cell-derived heart cell transplants to prevent arrhythmias. The drug-activated mechanism allows selective control of transplanted cells during early integration. This approach aims to improve the safety and viability of regenerative therapies for heart failure, reducing reliance on donor heart transplants.